Multiple-drug therapy is common in current clinical practice. Considerable attention [1] [2] [3] [4] has been focused on drug/ drug interactions such as those in drug distribution, drug metabolism, drug absorption, and receptor binding in multipledrug therapy. The significance of drug/metabolite interaction(s) in the biopharmaceutical fate of drugs was reported in the 1960s [5] [6] [7] [8] [9] [10] in addition to drug/drug interactions. Studenberg et al. also reported that the metabolites of phenobarbital inhibited the biotransformation of acetaminophen (APAP).
11) Recently, we have reported the effects of the concomitant use of N-acetyl-p-aminophenyl O-sulfate (APAPS, as potassium salt) [12] [13] [14] and its geometric isomers 15) with their parent drug APAP. In those reports, it was found that the tissue-to-plasma concentration ratio (K p ) of APAP was significantly increased in the liver, heart, kidney, and brain in the presence of APAPS but not by its geometric isomers. That is, APAPS appears to play a role as a biodistribution promoter. A similar phenomenon was observed when 4-hydroxyantipyrine (4-OH) was concomitantly administered with its parent drug, antipyrine, and the K p value of antipyrine in the brain and heart was significantly elevated. 16) These results prompted us to examine whether a similar interaction could be observed when APAPS or 4-OH was concomitantly administered with another drug that was not their parent drug.
In this report, the possibility of 4-OH, 4-hydroxyantipyrine O-sulfate (4-S, as ammonium salt), 16) APAPS, and APAP as biodistribution promoters was examined when these compounds were concomitantly used with citicoline (for 4-OH and 4-S), thiopental sodium (for 4-OH and 4-S), or antipyrine (for APAPS and APAP).
MATERIALS AND METHODS
Material 4-OH, 4-S, and APAPS were prepared in our laboratory. 12, 16) Citicoline and thiopental sodium were kindly supplied by Takeda Chemical Industries, Ltd. (Osaka, Japan) and Tanabe Seiyaku Co., Ltd. (Osaka, Japan), respectively. 4-OH was dissolved in 10 mM NaOH containing saline. 4-S, APAPS, citicoline, thiopental sodium, and antipyrine were dissolved in saline. APAP was dissolved in a mixture of propylene glycol and saline (2 : 3, v/v) before use. All chemicals and reagents were commercially available and of analytical grade or better. Animals Male Wistar rats (220-320 g) (Japan SLC, Hamamatsu, Japan) were used.
In Vivo Experiments The rats were fasted overnight before use, but allowed free access to water, and were fixed in the dorsal position under urethane anesthesia (900 mg/kg, i.p.). Polyethylene tubing was cannulated into both the left femoral vein and the right femoral artery.
Pharmacokinetics of Citicoline and Thiopental Sodium: Citicoline in saline (100 mg/kg) and thiopental sodium in saline (100 mg/kg) were intravenously administered through the right femoral vein at a volume of 1 mg/kg, respectively. Blood samples were collected through the cannula in the femoral vein at the appropriate time intervals. Plasma samples were obtained by centrifugation at 10000ϫg for 2 min, and all plasma samples were stored at Ϫ20°C until being analyzed.
Effect of 4-OH and 4-S on the K p of Citicoline and Thiopental Sodium: 4-OH and 4-S were intravenously administered at the initial dose (4.40, 6.13 mg/kg, respectively), followed by constant infusion (52.9, 44.2 mg/(kg · h), respectively) to maintain the target plasma concentration (10, 50 mg/ml, respectively) through the cannula in the left femoral vein throughout the experiments. Citicoline (100 mg/kg) or thiopental sodium (10 mg/kg) was intravenously administered at a steady-state concentration of 4-OH (or 4-S) 120 min after the start of infusion. Five minutes after the administration of citicoline (or thiopental sodium), blood was collected from the abdominal aorta, and the rats were decapi-The effects of 4-hydroxyantipyrine (4-OH), a major metabolite of antipyrine and its sulfate, 4-hydroxyantipyrine O-sulfate (4-S), on the pharmacokinetics of citicoline and thiopental sodium were investigated in rats. The concomitant use of 4-OH increased significantly the tissue-to-plasma concentration ratio (K p ) of citicoline in the brain and liver and that of thiopental sodium in the brain, liver, and heart, while 4-S did not affect them. The permeability clearance of blood-brain barrier (BBB) (K in ) and the total distribution volume (V dbr ) of citicoline were not affected by either 4-OH or 4-S. However, those of thiopental sodium were significantly increased by not only 4-OH but also by 4-S. On the other hand, the plasma concentration of antipyrine was significantly decreased by the intravenous bolus coadministration of N-acetyl-p-aminophenyl O-sulfate (APAPS) at steady-state plasma concentration of antipyrine. A similar reduction was not observed with the intravenous coadministration of acetaminophen (APAP). The K p value of antipyrine was significantly increased in the brain by the coadministration of APAPS, but was not affected by APAP. The increment in the drug distribution to the brain with the concomitant use of 4-OH (or APAPS) observed in this study is useful information for the application of drug combinations as biodistribution promoters. tated immediately. Tissue samples of the kidney, brain, liver, heart, spleen, and lung were extirpated and homogenized (15000ϫg) in isotonic phosphate buffer (pH 7.4) for 5 min. Five milliliters of ethyl acetate was added to 1 ml of the homogenate and the mixture was shaken for 1 h. After centrifugation (3000 rpm, 10 min, and 4°C), 4 ml of the upper layer was collected and evaporated in vacuo. The residue was dissolved in 300 ml of the mobile-phase solvent for HPLC measurement. Saline was used as a control.
Effect of 4-OH and 4-S on Blood-Brain Barrier (BBB) Permeability of Citicoline and Thiopental Sodium: Citicoline and thiopental sodium (100, 10 mg/kg, respectively) were administered to the jugular vein to achieve a steady state of 4-OH (plasma concentration was 10 mg/ml) or 4-S (plasma concentration was 50 mg/ml) 120 min after the start of infusion. Five, 30, or 60 min after the administration of citicoline or thiopental sodium, the rats were decapitated. Tissue samples of the brain were treated as described above, and the resulting samples were subjected to HPLC measurement. Saline was used as a control.
Effect of Bolus Challenge with APAPS and APAP on the Plasma Concentration Profile of Antipyrine: Antipyrine was intravenously administered at the initial dose (23.7 mg/kg), followed by a constant-rate infusion (24.1 mg/(kg · h)) to reach the target plasma concentration (100 mg/ml) through the cannula in the left femoral vein throughout the experiment. APAPS (100 mg/kg) and APAP (100 mg/kg) were respectively administered intravenously under a steady-state concentration of antipyrine at 1 and 2 h after the start of infusion, respectively.
Effect of APAPS and APAP on the K p of Antipyrine: APAPS (100 mg/kg) or APAP (100 mg/kg) was administered to the jugular vein at a steady state of antipyrine (plasma concentration was 100 mg/ml). Five minutes after administration, blood was collected from the abdominal aorta, and the rats were decapitated immediately. Tissue samples of the kidney, brain, liver, heart, spleen, and lung were treated as described above, and the resulting samples were subjected to HPLC measurement. Saline was used as a control.
In Vitro Experiments Effect of 4-OH and 4-S on the Apparent Partition Coefficient of Citicoline and Thiopental Sodium: A mixture of 4 ml of n-octanol-saturated phosphate buffer solution (50 mM, pH 7.4) containing 0.10 mM of citicoline (or thiopental sodium) and 0.10-1.0 mM of 4-OH (or 4-S) and 4 ml of n-octanol which was saturated with 50 mM phosphate buffer solution (pH 7.4) was shaken vigorously at room temperature for 30 min. The mixture was then shaken slowly at 37°C for 2 h. The upper layer (n-octanol layer) was diluted with methanol and the aqueous layer was diluted with purified water. The concentrations of the test compounds were determined by HPLC measurement.
Effect of 4-OH and 4-S on Protein Binding of Thiopental Sodium: To 450 ml of rat plasma preincubated at 37°C for 2 min was added 50 ml of thiopental sodium in saline (final concentration was 20 mg/ml) and the mixture was incubated at 37°C for 5 min. After incubation, the mixture was immediately ultrafiltrated through ULTRAFREE C3LGC (Japan Millipore, Tokyo, Japan). Centrifugation was continued for 30 min at 5000ϫg until 15% of the mixture was filtered. The filtrate was diluted with methanol (5-fold volume of the filtrate), and the concentration of the free drug (unbound drug) was determined by HPLC measurement.
Effect of APAPS and APAP on the Apparent Partition Coefficient of Antipyrine: A mixture of 4 ml of n-octanol-saturated 50 mM phosphate buffer solution (pH 7.4) containing 0.1 mM of antipyrine and 0.1-1 mM of APAPS (or APAP) and 4 ml of n-octanol which was saturated with 50 mM phosphate buffer solution (pH 7.4) was shaken vigorously at room temperature for 30 min. The mixture was then treated as described above, and the resulting samples were subjected to HPLC measurement.
Analytical Method The reverse-phase HPLC measurements for the detection of 4-OH, 4-S, APAPS, APAP, citicoline, thiopental sodium, and antipyrine were performed according to our previous reports. 12, 14, 16) Briefly, an HPLC apparatus (LC-10AD, Shimadzu, Kyoto, Japan) connected with an Inertsil ODS column (average particle size of 5 mm, 4.6 mm i.d.ϫ250 mm, GL Science, Inc., Tokyo, Japan) and a UV detector (SPD-10A, Shimadzu) operated at 254 nm (for 4-OH, 4-S, APAPS, APAP, citicoline, and antipyrine) or 289 nm (for thiopental sodium) were used. Mobile phases were 50 mM phosphate buffer solution (pH 7. The flow rate was 1.0 ml/min for all substances. Injection volumes were all 30 ml. The temperature tested was 40°C. Five hundred microliters of methanol was added to 100 ml of plasma sample to denaturalize the protein. After precipitation of protein by centrifugation (3000 rpmϫ 10 min), 60 ml of the supernatant filtered through a 0.45-mm pore-size membrane filter (Japan Millipore, Japan) was injected into the HPLC system for measurement. 4-OH, 4-S, APAPS, APAP, citicoline, thiopental sodium, and antipyrine were separately detected as symmetrical peaks.
Data Analysis Plasma concentrations (C p ) of 4-OH, 4-S, APAPS, APAP, citicoline, thiopental sodium, and antipyrine after intravenous administration were fitted to a biexponential curve, C p ϭA · exp(Ϫa · t)ϩB · exp(Ϫb · t), by the nonlinear least-squares regression program 17) with a weight of 1/C p . Pharmacokinetic parameters were calculated from the estimated parameters, A, B, a, and b, where the area under the plasma concentration time curve (AUC) was calculated from A/aϩB/b and the total body clearance, CL total , was equal to Dose/AUC. The elimination half-life, t 1/2 b, was calculated from ln 2/b. The mean residence time, MRT, was calculated as AUMC/AUC, with AUMC meaning the area under the first moment curve. The volume of the central compartment, V d1 , was calculated as Dose/(AϩB). The apparent volume of distribution at steady state, V dss , was calculated as Dose · AUMC/ AUC 18, 19) (Fig. 1) . K p values were estimated under the steady state of 4-OH, 4-S, or antipyrine according to the following equations:
where C t and C p are the concentrations of citicoline, thiopen-tal sodium, and antipyrine in the tissue and in the plasma, respectively; V t is the tissue volume; and V i and V e are the intracellular volume and the extracellular volume, respectively. The specific gravity of all tissues was assumed to be equal to 1. The K p values of citicoline, thiopental sodium, and antipyrine corrected by inulin space are shown in Figs. 2 and 3.
To determine partition coefficients, the initial concentrations of citicoline, thiopental sodium, and antipyrine in the aqueous layer and their concentrations in the aqueous layer after equilibrium were estimated, and finally the concentrations in the n-octanol layer after equilibrium were determined. The equation is shown by
where C octanol is the concentration of the drug in the n-octanol layer after equilibrium, C water is the concentration of the drug in the aqueous layer after equilibrium, and C o is the initial concentration of the drug in the aqueous layer.
The permeability clearance of BBB (K in ) was determined according to the graphic evaluation method of Blasberg et al. 20) and Gjedde. 21) Usually the equation of mass balance is shown by dC br /dtϭK in · C p ϪK out · C br (1) where C br is the concentration in the brain, C p is the concentration in plasma, and K out is the transport clearance from the brain to plasma. The efflux from the brain to plasma can be neglected (C br Ͻ ϽC p ) immediately following administration of the drug, so that Eqs. 2 and 3 can be derived from Eq. 1:
Therefore K in can be obtained using the concentration in the brain at T (h) after administration of the drug [C br (T)] and the AUC until T (h) after administration of the drug (∫ 0 T C p dt). The single time point method 22) using Eq. 3, however, sometimes yields an error in the revision of the dose of the remaining drug in the vascular system. On the other hand, the graphic evaluation method 20, 21) using doses of the drug in the brain at several T (h) after administration (q tot (T)) is shown by (4) where V dbr is the total value of plasma volume in the brain and volume of extravascular compartment, and C p (T) is the concentration in plasma at T (h) after administration of the drug. Equation 5 can be derived from Eq. 4: (5) From this equation, the regression line is obtained in which slope and intercept are K in and V dbr , respectively.
Statistical Analysis Statistical analyses of the effect of 4-OH and 4-S on the K p of citicoline and thiopental sodium, effect of 4-OH and 4-S on the BBB permeability of citicoline and thiopental sodium, effect of bolus challenge with APAPS and APAP on the plasma concentration profile of antipyrine, effect of APAPS and APAP on the K p of antipyrine, effect of 4-OH and 4-S on the apparent partition coefficient of citicoline and thiopental sodium, effect of 4-OH and 4-S on the protein binding of thiopental sodium, and effect of APAPS and APAP on the apparent partition coefficient of antipyrine were performed using Student's t-test. Analysis of variance (ANOVA) with Tukey's multiple comparison procedure was also performed. In all statistical testing, p values less than 0.05 were considered to be statistically significant.
RESULTS

Pharmacokinetics of Antipyrine, 4-OH, and 4-S
Plasma profiles of citicoline and thiopental sodium after intravenous administration (100 mg/kg, respectively) were apparently biexponential with time. The data were analyzed by a two-compartment model, as shown in Fig. 1 . Pharmacokinetic parameters of these compounds were estimated and are summarized in Table 1 . The pharmacokinetics of antipyrine were measured and described in a previous paper.
16)
Effect of 4-OH and 4-S on the K p of Citicoline and Thiopental Sodium
The K p values of citicoline and thiopental sodium 5 min after the intravenous bolus administration of these drugs under the steady-state concentration of 4-OH or 4-S are shown in Fig. 2 . The K p value of citicoline was increased significantly in the brain and liver by the ad- Fig. 1 . Pharmacokinetic Model for Intravenous Administration ministration of 4-OH and that of thiopental sodium was also increased significantly in the brain, liver, and heart by the administration of 4-OH, but the values were not affected by 4-S.
Effect of 4-OH and 4-S on the BBB Permeability of Citicoline and Thiopental Sodium
The concentrations of citicoline and thiopental sodium in the brain after intravenous administration under the steady-state plasma concentration of 4-OH or 4-S were determined and plotted according to the graphic evaluation method. 20, 21) The results are shown in Fig. 4 . The permeability clearance of BBB (K in ) and the total distribution volume (V dbr ) of these drugs are summarized in Table 2 . The K in and V dbr of citicoline were Graphical evaluation method using doses of the drug in the brain at several T (h) after administration of the drug (q tot (T)), shown by q tot (T)ϭK in ∫ 0 T C p dtϩV dbr · C p (T) (Eq. 4), where K in is the permeability clearance of BBB, ∫ 0 T C p dt is the area under the plasma concentration-time curve until T (h) after the administration, V dbr is the total value of plasma volume in the brain and volume of the extravascular compartment, C p (T) is the concentration in plasma at T (h) after drug administration. Equation 5 can be derived from the Eq. 4: q tot (T)/C p (T)ϭK in ∫ 0 T C p dt/C p (T)ϩV dbr (Eq. 5). From this equation, the regression line is obtained in which slope and intercept are K in and V dbr , respectively (see Fig. 4 ).
only slightly affected by the presence of either 4-OH or 4-S. On the other hand, the K in and V dbr values of thiopental sodium under the steady-state plasma concentration of 4-OH were about 4-5 times as large as those of the control. The K in value of thiopental sodium under the steady-state plasma concentration of 4-S was 2 times larger than that of the control, and the V dbr value was 9 times the control.
Effect of 4-OH and 4-S on the Apparent Partition Coefficient of Citicoline and Thiopental Sodium
Apparent partition coefficient of citicoline and thiopental sodium in the presence of 4-OH (or 4-S) is shown in Fig. 5 . In the case of citicoline, the partition coefficient increased with the addition of 3-5-fold 4-OH, although it was not affected by the addition of 4-S. Similarly, the coefficient of thiopental sodium increased with the addition of more than 3-fold 4-OH, but no change was observed with the addition of 4-S. Table 3 , approximately 71% of thiopental sodium was bound to plasma protein. A 14-20% reduction of this binding ratio was observed with the addition of 4-OH or 4-S. However, no dose-dependent decline was recognized.
Effect of 4-OH and 4-S on the Protein Binding of Thiopental Sodium As shown in
Effect of Bolus Challenge with APAPS and APAP on the Plasma Concentration Profile of Antipyrine
The effect of intravenously administered APAPS (100 mg/kg) on the steady-state plasma concentration of antipyrine is shown in Fig. 6 . The plasma concentration of antipyrine was drastically decreased with the coadministration of APAPS. However, this phenomenon was transient and the plasma concentration of antipyrine was restored to the original level within 10-20 min. A similar reduction was not observed with the intravenous coadministration of APAP.
Effect of APAPS and APAP on the K p of Antipyrine The K p values of antipyrine 5 min after the intravenous bolus administration of APAPS (100 mg/kg) or APAP (10 mg/kg) under the steady-state concentration of antipyrine are shown in Fig. 3 . The K p value was significantly increased in the brain with the administration of APAPS, but was not affected by APAP.
Effect of APAPS and APAP on the Apparent Partition Coefficient of Antipyrine The apparent partition coefficient of antipyrine in the presence of APAPS (or APAP) is shown in Fig. 7 . In the case of APAPS, this partition coefficient increased with the addition of APAPS until equivalent APAPS was added. After that it reached a plateau. Almost the same phenomenon was observed with the addition of APAP.
DISCUSSION
The pharmacokinetics of drugs are sometimes influenced by biopharmaceutical interactions with their metabolitees. [5] [6] [7] [8] [9] [10] [12] [13] [14] [15] In the previous paper, the effects of 4-OH (metabolite of antipyrine) and 4-S (sulfate of 4-OH) on the pharmacokinetics of antipyrine were investigated in rats. 16) In this report, the effects of 4-OH and 4-S on the pharmacokinetics of citicoline and thiopental sodium were investigated in rats. The effects of APAPS and APAP on the pharmacoki- netics of antipyrine were also investigated. The K p value of citicoline 5 min after its administration with concomitant 4-OH was significantly increased in the brain and liver and that of thiopental sodium was also rose significantly in the brain, liver, and heart with coadministration of 4-OH, while 4-S did not affect them. On the other hand, the plasma profiles of citicoline and thiopental sodium after intravenous administration were apparently biexponential with time and those data were analyzed by a two-compartment model. Therefore the elevation of the K p values of citicoline and thiopental sodium can be explained as follows: the stage 5 min after administration corresponds to a distribution phase (a phase) in the blood pharmacokinetic profile and in the route of distribution. The increases in K p values of citicoline in the brain and liver and of thiopental sodium in the brain, liver, and heart were caused by enhancement of distribution speed resulting from the elevation of partition coefficients in the presence of 4-OH.
As the K p values of both citicoline and thiopental sodium 5 min after administration with the concomitant use of 4-OH were significantly increased in the brain, we next examined the effects of 4-OH and 4-S on the K in and V dbr values of citicoline and thiopental sodium. In the case of citicoline, both K in and V dbr were only slightly affected by the concomitant administration of either 4-OH or 4-S. On the other hand, those of thiopental sodium were significantly increased by the concomitant use of not only 4-OH but also 4-S. Therefore it appears that the change in K in and V dbr values of the drugs caused by 4-OH or 4-S are not directly related to the elevation of their K p values in the brain.
In general, an intravenously administered drug must pass through the plasma membrane for distribution to the tissues, and the partition coefficient and the protein binding ratio of the drug are factors allowing membrane transport. In this experiment, only 4-OH enhanced the apparent partition coefficients of citicoline and thiopental sodium, but these were not dose dependent. Furthermore, the partition coefficients of these drugs were not increased with the concomitant use of 4-S. These results suggest that the change in the partition coefficient was closely related to the mechanism of the elevation of the K p values of citicoline and thiopental sodium. One of the effects resulting from changing the partition coefficient of the compound is the salting-out effect. However, the concentration of the drugs (citicoline and thiopental sodium) and 4-OH were only 0.10 mM and 0.10-1.0 mM, respectively, while 50 mM phosphate buffer solution was employed in our experiment. That is, the salt concentration of the buffer solution was 50-500-fold those of the drugs and 4-OH. It would appear very difficult for the migration of a small amount of 4-OH from the water layer to the organic layer to change the partition coefficient of citicoline (or thiopental sodium) under our conditions. The salting-out effect was thus neglected. At present, it is not clear why the partition coefficients of the drugs were increased with the concomitant administration of 4-OH. The relationship between the elevation of the K p values and the change in the partition coefficient of the drugs is also not clear. Furthermore, if the change in this coefficient were to cause an enhancement in their K p values, K p values should increase in all organs; this was not the result, however. We therefore believe that there was some type of interaction between citicoline (or thiopental sodium) and 4-OH, and that this interaction increased the partition coefficient of the drugs and also specifically caused the enhancement of their K p values in the brain and other tissues. At present, however, we have no plausible explanation of what type of interaction this was or why this phenomenon occurred.
Thiopental sodium is known to have relatively strong affinity to the plasma protein (75% in healthy human adults). Therefore the effect of 4-OH and 4-S on the protein binding of thiopental sodium was evaluated, and its protein binding ratio was found to be reduced (about 10-20%) with concomitant 4-OH (or 4-S). No dose-dependent decline was recognized in this study. Considering the distribution volume of thiopental sodium (526Ϯ41.6 ml/kg for V d1 and 720Ϯ252 ml/kg for V dss , see Table 1 ), the increase in unbound antipyrine in plasma by 4-OH appeared to make a relatively small contribution to the enhancement of the distribution to tissues.
We have reported that the K p value of APAP was significantly increased in the liver, heart, kidney, and brain with the concomitant administration of APAPS. [12] [13] [14] To study the biodistribution promoter further, we employed APAPS and APAP as candidates for biodistribution promoters and antipyrine as the active drug. The plasma concentration of antipyrine was drastically decreased by the intravenous bolus coadministration of APAPS at steady-state plasma concentration of antipyrine. This phenomenon was transient, and the plasma concentration of antipyrine was restored to the original level within 10-20 min. It appears that this reduction was caused by the distribution of antipyrine to tissues. No similar decrease was observed with the intravenous coadministration of APAP. The K p values of antipyrine 5 min after the intravenous administration of APAPS (and APAP) under the steady-state concentration of antipyrine are shown in Fig. 3 . The K p value was significantly increased in the brain with the administration of APAPS, but was not affected by APAP. On the other hand, the apparent partition coefficient of antipyrine was significantly increased with the addition of APAPS and APAP, respectively. It is also not clear why the partition coefficient of antipyrine was enhanced with the addition of APAPS or APAP.
Recently, various methods such as the BBB basic amine transporter, which is used for the distribution of hydrophilic and charged compounds to the brain, 23) and nerve growth factor, which is modified by polyamine, 24) have been suggested as drug delivery systems to the brain. Increased BBB permeability by stress exposure has also been reported. 25) From another viewpoint, increased drug distribution to the brain with the concomitant use of 4-OH or APAPS as recognized in this study is information useful for the development of drug combinations as a biodistribution promoters.
CONCLUSIONS
In the present study, it was determined that the concomitant administration of 4-OH significantly enhanced the K p value of citicoline in the brain and liver and that of thiopental sodium in the brain, liver, and heart, while 4-S did not affect them. The K in and V dbr values of citicoline were not affected by either 4-OH or 4-S, although those of thiopental sodium were significantly increased not only by 4-OH but also by 4-S.
4-OH enhanced the apparent partition coefficients of citicoline and thiopental sodium, but not dose dependently. Furthermore, the partition coefficients of these drugs were not increased with concomitant 4-S.
The plasma concentration of antipyrine was remarkably decreased by the intravenous bolus coadministration of APAPS at steady-state plasma concentration of antipyrine. No similar reduction was observed with the intravenous coadministration of APAP. The K p value of antipyrine was significantly increased in the brain with the coadministration of APAPS, but was not affected by APAP. On the other hand, the apparent partition coefficient of antipyrine was significantly increased with the addition of APAPS and APAP.
